TAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple Paradigms

It remains to be seen if it alters the negative symptom course. But treating cognitive issues will definitely help many people.